ATI Pharmocology Exam Fletcher NRSG 106 | Nurselytic

Questions 47

ATI RN

Home > ATI RN > ATI Pharmacology > ATI Pharmocology Exam Fletcher NRSG 106
ATI RN Test Bank

ATI Pharmocology Exam Fletcher NRSG 106 Questions

Extract:


Question 1 of 5

When evaluating a patient who is taking orlistat, which is an intended therapeutic effect?

Correct Answer: A

Rationale: The correct answer is A: Decreased weight. Orlistat is a weight-loss medication that works by inhibiting the absorption of dietary fats. This leads to reduced calorie intake and ultimately results in weight loss. Increased appetite (
B) would be an unintended effect as orlistat is meant to decrease appetite by promoting a feeling of fullness. Decreased hyperactivity (
C) and increased wakefulness (
D) are not associated with orlistat use.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

When a patient is taking an anticholinergic such as benztropine as part of the treatment for Parkinson's disease, the nurse should include which information in the teaching plan?
A nurse is providing teaching to a client who has a new diagnosis of Parkinson's disease. On which of the following medications should the nurse prepare to instruct the client?
The nurse is reviewing the use of central nervous system stimulants. Which of these are indications for this class of drugs? (Select all that apply.)
The nurse is caring for a 64-year-old male client with diabetes who is being treated with a nonselective beta-blocker. What health education should the nurse prioritize with this client?
When a patient is taking an adrenergic agonist drug, the nurse expects to observe which effect?

Access More Questions!

ATI RN Basic

$89/ 30 days

 

ATI RN Premium

$150/ 90 days